$6M Takeda Verdict Reinstated In 1st Actos Cancer Trial

By Kurt Orzeck (July 16, 2015, 3:54 PM EDT) -- A California state appeals court on Thursday reinstated a $6.5 million jury award against Japan's Takeda Pharmaceutical Co. Ltd. in the first product liability trial over claims its diabetes drug Actos caused cancer, a verdict the trial judge tossed more than two years ago....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!